LobbyingNexalin Technology lobbying by quarter
Nexalin Technology NXL's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $80K. Its first report covers Q3 2023; the issues it reports most are Defense and Health Issues.
Nexalin TechnologyNXL
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $80K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2023 | $20K | 1 |
| Q4 2023 | $30K | 1 |
| Q1 2024 | $20K | 1 |
| Q2 2024 | $20K | 1 |
| Q3 2024 | $20K | 1 |
| Q4 2024 | $20K | 1 |
| Q1 2025 | $20K | 1 |
| Q2 2025 | $20K | 1 |
| Q3 2025 | $30K | 1 |
| Q4 2025 | $40K | 1 |
| Q1 2026 | $20K | 1 |
| Q2 2026 | $20K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Defense$93.3K · 12 reports
- Health issues$93.3K · 12 reports
- Veterans$93.3K · 12 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Defense, Dept of (DOD)12 reports
- Health & Human Services, Dept of (HHS)12 reports
- HOUSE OF REPRESENTATIVES12 reports
- SENATE12 reports
- Veterans Affairs, Dept of (VA)12 reports
Firms it paid
| Firm | ||
|---|---|---|
| RK Strategies | $280K | 12 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/18for Q2 | RK Strategies | $20K |
| 04/20for Q1 | RK Strategies | $20K |
| 01/20for Q4 2025 | RK Strategies | $40K |
| 25/10/20for Q3 2025 | RK Strategies | $30K |
| 25/07/21for Q2 2025 | RK Strategies | $20K |
| 25/04/21for Q1 2025 | RK Strategies | $20K |
| 25/01/20for Q4 2024 | RK Strategies | $20K |
| 24/10/20for Q3 2024 | RK Strategies | $20K |
| 24/07/18for Q2 2024 | RK Strategies | $20K |
| 24/04/21for Q1 2024 | RK Strategies | $20K |
| 24/01/20for Q4 2023 | RK Strategies | $30K |
| 23/10/20for Q3 2023 | RK Strategies | $20K |
| 23/08/25for Q3 2023 | RK Strategies | Under $5,000 |